- InVivo Therapeutics' (NVIV.OB) acting CFO Sean Moran resigns.
- New CEO Michael Astrue will serve as "principal financial officer" until a replacement is found.
- Moran's exit causes the company to cancel tomorrow's presentation at the Rodman and Renshaw Healthcare Conference. (PR)
on your portfolio: